| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/13/2004 | US6762291 Used to modify insects and worms, or cultured cells, resulting in p53 expression or mis-expression; modified organisms or cells are used in screening assays to identify potential pesticidal agents or therapeutics that interact with p53 |
| 07/13/2004 | US6762290 Includes rna ligands that inhibit the interaction of a vegf receptor with vegf |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762280 High throughput assays for the proteotytic activities of clostridial neurotoxins |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6762062 Determination cholesterol concentration in low density lipoproteins |
| 07/13/2004 | US6762059 Methods and apparatuses for characterization of single polymers |
| 07/13/2004 | US6762058 Examination method of buffer capacity of saliva and examination instrument of buffer capacity of saliva |
| 07/13/2004 | US6762057 Porous separation apparatus that includes a sample column and a detector that is disposed along the column to detect the presence of and identify each constituent that passes by; used in chromatographic separation, electrophoretic separation |
| 07/13/2004 | US6762056 Rapid method for determining potential binding sites of a protein |
| 07/13/2004 | US6762055 Method for preparation of hematology blood control |
| 07/13/2004 | US6762054 Optical analysis of mixed solution; obtain sample, expose to transmitted light, monitor particles in solution |
| 07/13/2004 | US6762050 Manufacture of a microsensor device and a method for evaluating the function of a liquid by the use thereof |
| 07/13/2004 | US6762041 Reacting transferase or transglutaminase (calcium independent/dependent) with protein (insulin, albumin, egg white lysozyme) to label carboxyamide nitrogen of glutamic acid residue |
| 07/13/2004 | US6762036 Apparatus for detecting cellular responses following exposure to test compounds |
| 07/13/2004 | US6762035 Method and test strips for the measurement of fat loss during weight loss programs |
| 07/13/2004 | US6762033 Method for determining the fertility of mammals, especially humans |
| 07/13/2004 | US6762032 Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
| 07/13/2004 | US6762029 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6762021 Method for diagnosis of crohn's disease |
| 07/13/2004 | US6762020 Methods of diagnosing breast cancer |
| 07/13/2004 | US6762019 Use in activated slides for making microarrays of nucleic acids; monomers with pendant epoxy groups to immobilize biological targets, diluent monomers or polymers, and monomers having a photoreactive group to surface treat the substrate |
| 07/13/2004 | US6762017 Control for complete blood count analysis system |
| 07/13/2004 | US6761876 Methods for introducing helterologous cells into fish |
| 07/13/2004 | US6761856 Apparatus for determining platelet inhibitor response |
| 07/13/2004 | US6761810 Automated apparatus including a robotic arm for loading samples into wells for first dimension electrophoresis separation |
| 07/13/2004 | US6761789 Method of manufacturing a soft hearing aid |
| 07/13/2004 | US6761076 Portable suction lysimeter |
| 07/13/2004 | CA2455044A1 Strips for analyzing samples |
| 07/13/2004 | CA2202913C Antibody reagent for detecting dissecting aortic aneurysm and uses thereof |
| 07/13/2004 | CA2163858C Improved method and analytical system for performing fibrinogen assays accurately, rapidly and simply |
| 07/13/2004 | CA2163212C Therapeutic compounds |
| 07/13/2004 | CA2144335C Pit detector and method |
| 07/13/2004 | CA2052413C Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods |
| 07/08/2004 | WO2004057345A2 Transport device for transporting test strips in an analysis system |
| 07/08/2004 | WO2004057344A1 Diagnostics and therapeutics for diseases associated with muscarinic acetylcholine receptor m2 (m2) |
| 07/08/2004 | WO2004057343A2 Detection or determination of variants of factor xiia |
| 07/08/2004 | WO2004057342A2 Method for enhanced accuracy in predicting the elution times of peptides using liquid separations or chromatography |
| 07/08/2004 | WO2004057341A2 Cvd assay |
| 07/08/2004 | WO2004057340A1 Synthesis and screening of ligands using x-ray crystallography |
| 07/08/2004 | WO2004057339A1 Elisa method for the detection of guanylate binding protein 1 (gbp-1) |
| 07/08/2004 | WO2004057338A1 Diagnostics and therapeutics for diseases assosciated with 5-hydroxytryptamine (serotonin) receptor 2b (5-hteb) |
| 07/08/2004 | WO2004057337A1 Method for analyzing tumor agressivity comprising measurement of polymerized actin |
| 07/08/2004 | WO2004057336A2 Use of nicotinamide n-methyltransferase as a marker for colorectal cancer |
| 07/08/2004 | WO2004057335A1 Biochip |
| 07/08/2004 | WO2004057334A1 Dna chip comprising a microarray made of an microelectrode system |
| 07/08/2004 | WO2004057333A1 Millisecond activation switch for seven-transmembrane proteins |
| 07/08/2004 | WO2004057332A1 Microporous filtration based dot immunoassay device for method for screening of analytes and method of use |
| 07/08/2004 | WO2004057331A1 Colorimetric sensors constructed of diacetylene materials |
| 07/08/2004 | WO2004057330A1 Method of screening cell growth inhibitor and cell growth inhibitor |
| 07/08/2004 | WO2004057329A1 Diagnostics and therapeutics for diseases associated with muscarinic acetylcholine receptor m1 (acm1) |
| 07/08/2004 | WO2004057328A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor 38 (gpr38) |
| 07/08/2004 | WO2004057327A1 A novel assay to screen for anti-malarials |
| 07/08/2004 | WO2004057320A1 System for measuring the presence and concentration of different immiscible liquids in a sample |
| 07/08/2004 | WO2004057309A1 Method of measuring composition of multicomponent mixture gas and composition measuring apparatus |
| 07/08/2004 | WO2004057305A2 A milk conveyer device |
| 07/08/2004 | WO2004057301A2 Isolation and confirmation of analytes from test devices |
| 07/08/2004 | WO2004057294A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 2c (5-ht2c) |
| 07/08/2004 | WO2004057032A1 Methods for identifying functionally related genes and drug targets |
| 07/08/2004 | WO2004057028A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 07/08/2004 | WO2004057016A2 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN |
| 07/08/2004 | WO2004057014A2 Luminescent polymers and methods of use thereof |
| 07/08/2004 | WO2004056992A1 Three-dimensional structure of lipocalin-type prostaglandin d synthase and utilization of the same |
| 07/08/2004 | WO2004056871A2 Peptides and their use for the treatment of hiv infections |
| 07/08/2004 | WO2004056869A1 Ghrelin receptor inverse agonist for regulation of feeding behaviours |
| 07/08/2004 | WO2004056865A2 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | WO2004056862A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | WO2004056861A2 Glycoisoforms of adiponectin and uses thereof |
| 07/08/2004 | WO2004056857A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes |
| 07/08/2004 | WO2004056855A1 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them |
| 07/08/2004 | WO2004056854A1 Molecular transporters for intracellular delivery and their applications |
| 07/08/2004 | WO2004056851A1 Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response |
| 07/08/2004 | WO2004056665A1 Liquid storage container and cartridge |
| 07/08/2004 | WO2004056470A1 Surface treatment |
| 07/08/2004 | WO2004056456A1 Generation of efficacy, toxicity and disease signatures and methods of use thereof |
| 07/08/2004 | WO2004056398A1 Isotope labeled camptothecin derivatives |
| 07/08/2004 | WO2004056315A2 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 07/08/2004 | WO2004056309A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/08/2004 | WO2004056269A1 Body fluid testing device |
| 07/08/2004 | WO2004056265A2 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 07/08/2004 | WO2004042361A3 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 07/08/2004 | WO2004040253A3 Secretion-testing article |
| 07/08/2004 | WO2004038386A3 System and method for determining an air content, air release ability and for foam forming on oil surfaces |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004034018A3 Multihued labels |
| 07/08/2004 | WO2004030719A3 Hemostatic puncture closure with depth indicator |
| 07/08/2004 | WO2004028464A3 Methods and compositions for modification of splicing of pre-mrna |
| 07/08/2004 | WO2004027021A3 Device and methods for isolating target cells |
| 07/08/2004 | WO2004026931A3 Functionalized materials and methods of using same |
| 07/08/2004 | WO2004025294A3 Method for locating ligands bonding to a drug target by means of nmr displacement experiments |
| 07/08/2004 | WO2004024121A3 Methods of measuring the dissolution rates of an analyte in a non-aqueous liquid composition |
| 07/08/2004 | WO2004017900A3 Assay for thrombocytopenia associated with administration of platelet gpiib-iiia receptor antagonists |
| 07/08/2004 | WO2004016727B1 Determination and/or control of reactor environmental conditions |
| 07/08/2004 | WO2004015539A3 Managing and processing self-monitoring blood glucose |
| 07/08/2004 | WO2004015081A3 Methods for treating circadian rhythm phase disturbances |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2004011904A3 Quality assurance for high-throughput bioassay methods |